TABLE 4.
C–CT |
Assessment Only Control |
|||||||
---|---|---|---|---|---|---|---|---|
Scale | n | M | SD | n | M | SD | t(N–2) | d |
End of experimental phase (8 months post-A–CT) | ||||||||
Best AFF | 30 | 126.7 | 52.9 | 32 | 100.7 | 68.3 | -1.67† | 0.42 |
Best AUT | 30 | -7.7 | 32.2 | 32 | -28.5 | 31.6 | -2.57* | 0.65 |
Worst AFF | 30 | -18.8 | 85.8 | 32 | -35.9 | 69.2 | -0.87 | 0.22 |
Worst AUT | 30 | -5.4 | 33.0 | 32 | -7.2 | 37.7 | -0.20 | 0.05 |
End of follow-up phase (24 months post-A–CT) | ||||||||
Best AFF | 22 | 145.7 | 39.3 | 21 | 114.5 | 75.4 | -1.71† | 0.52 |
Best AUT | 22 | 1.0 | 29.0 | 21 | -25.6 | 29.3 | -2.98* | 0.91 |
Worst AFF | 22 | -3.1 | 91.3 | 21 | -48.9 | 98.1 | -1.58 | 0.48 |
Worst AUT | 22 | -0.4 | 24.7 | 21 | -14.4 | 44.0 | -1.30 | 0.40 |
Note. Effect size d values≥ 0.20, 0.50, and 0.80 mark small, medium, and large effects, respectively (Cohen, 1988). C–CT = continuation phase cognitive therapy; A–CT = acute phase cognitve therapy; best = ratings at one’s best; AFF = afilliation; AUT = autonomy; worst = ratings at one’s worst.
p < .05, two-tailed.
p ≤ .05, one-tailed.